Complement Mediated Apoptosis Leads to the Loss of Retinal Ganglion Cells in Animal Model of Glaucoma

Overview

Journal Mol Immunol

Specialties Allergy & Immunology
Molecular Biology

Date 2011 Aug 9

PMID 21821293

Citations 38

Authors

Purushottam Jha

Himanshu Banda

Ruslana Tytarenko

P S Bora

N S Bora

Affiliations

Soon will be listed here.

Abstract

This study investigated the role of complement in the protection of retinal ganglion cells (RGCs) in chronic ocular hypertension model of glaucoma. Intraocular pressure (IOP) was elevated in the right eye of Lewis rats by laser photocoagulation (two treatments, 7days apart) of episcleral and limbal veins. Left eye did not receive laser treatment and served as control. Animals were injected with cobra venom factor every fifth day starting day 7 after first laser, to deplete the complement system. Animals were sacrificed at 6-week post-laser. Levels of C3 split products and membrane attack complex (MAC) were elevated in the retina of eyes with increased IOP and complement depletion reduced the loss of Brn3a(+) RGCs accompanied by decreased expression of GFAP and reduced MAC deposition. In complement depleted rats with increased IOP, reduced TUNEL(+) cells in ganglion cell layer, and decreased levels of active caspase-8 and active caspase-9 was observed compared to PBS treated complement sufficient rats with increased IOP. Interestingly, complement depletion also resulted in reduction of calcium influx and levels of BAD in the retinal cells of the eyes with increased IOP. Together, our results provide evidence that complement mediated apoptosis plays a pivotal role in the loss of RGCs in chronic ocular hypertension model of glaucoma.

Citing Articles

Acute depletion of complement C3 with cobra venom factor attenuates memory deficits induced by status epilepticus.

Schartz N, Li Y, Sommer A, Brewster A Epilepsia Open. 2024; 9(6):2173-2185.

PMID: 39501495 PMC: 11633766. DOI: 10.1002/epi4.13030.

Corneal application of SOCS1/3 peptides for the treatment of eye diseases mediated by inflammation and oxidative stress.

Ahmed C, Johnson H, Lewin A Front Immunol. 2024; 15:1416181.

PMID: 39104531 PMC: 11298391. DOI: 10.3389/fimmu.2024.1416181.

Advances in aqueous humor proteomics for biomarker discovery and disease mechanisms exploration: a spotlight on primary open angle glaucoma.

Beutgen V, Graumann J Front Mol Neurosci. 2024; 17:1397461.

PMID: 38721264 PMC: 11076703. DOI: 10.3389/fnmol.2024.1397461.

In a novel autoimmune and high-pressure glaucoma model a complex immune response is induced.

Reinehr S, Wulf J, Theile J, Schulte K, Peters M, Fuchshofer R Front Immunol. 2024; 15:1296178.

PMID: 38515755 PMC: 10955086. DOI: 10.3389/fimmu.2024.1296178.

The Role of Complement Dysregulation in Glaucoma.

Hoppe C, Gregory-Ksander M Int J Mol Sci. 2024; 25(4).

PMID: 38396986 PMC: 10888626. DOI: 10.3390/ijms25042307.

References

Kuehn M, Kim C, Ostojic J, Bellin M, Alward W, Stone E . Retinal synthesis and deposition of complement components induced by ocular hypertension. Exp Eye Res. 2006; 83(3):620-8. DOI: 10.1016/j.exer.2006.03.002. View

Wang H, Pathan N, Ethell I, Krajewski S, Yamaguchi Y, Shibasaki F . Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science. 1999; 284(5412):339-43. DOI: 10.1126/science.284.5412.339. View

Kuehn M, Kim C, Jiang B, Dumitrescu A, Kwon Y . Disruption of the complement cascade delays retinal ganglion cell death following retinal ischemia-reperfusion. Exp Eye Res. 2008; 87(2):89-95. DOI: 10.1016/j.exer.2008.04.012. View

Qu J, Wang D, Grosskreutz C . Mechanisms of retinal ganglion cell injury and defense in glaucoma. Exp Eye Res. 2010; 91(1):48-53. PMC: 3378677. DOI: 10.1016/j.exer.2010.04.002. View

Nadal-Nicolas F, Jimenez-Lopez M, Sobrado-Calvo P, Nieto-Lopez L, Canovas-Martinez I, Salinas-Navarro M . Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. Invest Ophthalmol Vis Sci. 2009; 50(8):3860-8. DOI: 10.1167/iovs.08-3267. View

Stevens B, Allen N, Vazquez L, Howell G, Christopherson K, Nouri N . The classical complement cascade mediates CNS synapse elimination. Cell. 2007; 131(6):1164-78. DOI: 10.1016/j.cell.2007.10.036. View

Cole D, Morgan B . Beyond lysis: how complement influences cell fate. Clin Sci (Lond). 2003; 104(5):455-66. DOI: 10.1042/CS20020362. View

Bora N, Jha P, Bora P . The role of complement in ocular pathology. Semin Immunopathol. 2008; 30(2):85-95. PMC: 2315691. DOI: 10.1007/s00281-008-0110-y. View

Hughes J, Nangaku M, Alpers C, Shankland S, Couser W, Johnson R . C5b-9 membrane attack complex mediates endothelial cell apoptosis in experimental glomerulonephritis. Am J Physiol Renal Physiol. 2000; 278(5):F747-57. DOI: 10.1152/ajprenal.2000.278.5.F747. View

10.

Shields M, Mccoy R, Shelburne J . Immunofluorescent studies on the trabecular meshwork in open-angle glaucoma. Invest Ophthalmol. 1976; 15(12):1014-7. View

11.

Carney D, Lang T, Shin M . Multiple signal messengers generated by terminal complement complexes and their role in terminal complement complex elimination. J Immunol. 1990; 145(2):623-9. View

12.

Tezel G, Yang X, Luo C, Kain A, Powell D, Kuehn M . Oxidative stress and the regulation of complement activation in human glaucoma. Invest Ophthalmol Vis Sci. 2010; 51(10):5071-82. PMC: 3066595. DOI: 10.1167/iovs.10-5289. View

13.

Nickells R . From ocular hypertension to ganglion cell death: a theoretical sequence of events leading to glaucoma. Can J Ophthalmol. 2007; 42(2):278-87. DOI: 10.3129/can j ophthalmol.i07-036. View

14.

Ahmed F, Brown K, Stephan D, Morrison J, Johnson E, Tomarev S . Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure. Invest Ophthalmol Vis Sci. 2004; 45(4):1247-58. DOI: 10.1167/iovs.03-1123. View

15.

Lomonosova E, Chinnadurai G . BH3-only proteins in apoptosis and beyond: an overview. Oncogene. 2009; 27 Suppl 1:S2-19. PMC: 2928556. DOI: 10.1038/onc.2009.39. View

16.

Huang W, Fileta J, Dobberfuhl A, Filippopolous T, Guo Y, Kwon G . Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma. Proc Natl Acad Sci U S A. 2005; 102(34):12242-7. PMC: 1186026. DOI: 10.1073/pnas.0505138102. View

17.

Grus F, Sun D . Immunological mechanisms in glaucoma. Semin Immunopathol. 2008; 30(2):121-6. DOI: 10.1007/s00281-008-0105-8. View

18.

Stasi K, Nagel D, Yang X, Wang R, Ren L, Podos S . Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest Ophthalmol Vis Sci. 2006; 47(3):1024-9. DOI: 10.1167/iovs.05-0830. View

19.

Ji J, Elyaman W, Yip H, Lee V, Yick L, Hugon J . CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway. Eur J Neurosci. 2004; 19(2):265-72. DOI: 10.1111/j.0953-816x.2003.03107.x. View

20.

Jha P, Sohn J, Xu Q, Nishihori H, Wang Y, Nishihori S . The complement system plays a critical role in the development of experimental autoimmune anterior uveitis. Invest Ophthalmol Vis Sci. 2006; 47(3):1030-8. PMC: 1975680. DOI: 10.1167/iovs.05-1062. View